1. Home
  2. MI vs BIAF Comparison

MI vs BIAF Comparison

Compare MI & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NFT Limited

MI

NFT Limited

HOLD

Current Price

$0.31

Market Cap

5.2M

ML Signal

HOLD

Logo bioAffinity Technologies Inc.

BIAF

bioAffinity Technologies Inc.

HOLD

Current Price

$3.97

Market Cap

4.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MI
BIAF
Founded
2009
2014
Country
Hong Kong
United States
Employees
N/A
57
Industry
Catalog/Specialty Distribution
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2M
4.6M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
MI
BIAF
Price
$0.31
$3.97
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
1.4M
19.0M
Earning Date
05-07-2026
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$20.95
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.26
$0.16
52 Week High
$6.70
$13.50

Technical Indicators

Market Signals
Indicator
MI
BIAF
Relative Strength Index (RSI) 17.68 62.76
Support Level N/A $0.76
Resistance Level $4.28 $5.38
Average True Range (ATR) 0.07 0.92
MACD 0.04 0.13
Stochastic Oscillator 11.91 65.86

Price Performance

Historical Comparison
MI
BIAF

About MI NFT Limited

NFT Ltd operates an online electronic platform for offering and trading artwork. Through its platform, the company allows artists/art dealers/owners to access a much bigger art trading market where artists can engage with a wide range of investors. Its platform also invests in high-end artwork accessible to ordinary people without financial resources. The company's trading platforms comprise the sale of calligraphies and paintings, jewelry, and precious stones. It generates revenue in the form of services in connection with the offering and trading of artwork on its system, consisting of listing fees, trading commissions, and management fees.

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

Share on Social Networks: